In vitro pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms.
about
Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniaeWhat we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Prediction of in vivo and in vitro infection model results using a semimechanistic model of avibactam and aztreonam combination against multidrug resistant organisms.Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa.Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
In vitro pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In vitro pharmacokinetics/phar ...... treonam against MDR organisms.
@en
type
label
In vitro pharmacokinetics/phar ...... treonam against MDR organisms.
@en
prefLabel
In vitro pharmacokinetics/phar ...... treonam against MDR organisms.
@en
P2093
P2860
P356
P1476
In vitro pharmacokinetics/phar ...... treonam against MDR organisms.
@en
P2093
Christian Frank
Clemens Lux
Hartmut Derendorf
Kathrin I Löblein
Luning Zhuang
Marie-Eve Beaudoin
Marlene Kissel
Midas B Mulder
Robin Tremmel
Severin Strasser
P2860
P304
P356
10.1093/JAC/DKW082
P407
P577
2016-04-21T00:00:00Z